Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Carter

Showing results (11-20 of 145) with videos related to

Pageof 15
Sort By:
IAPAC Monthly|January 26, 2007
Focus on hepatitis. HCV protease inhibitor does well in early clinical trialMichael Carter
IAPAC Monthly|May 26, 2007
Frequent methamphetamine use, primary NNRTI resistanceMichael Carter
IAPAC Monthly|May 26, 2007
Focus on hepatitis. HIV/HCV coinfection and CVD riskMichael Carter
IAPAC Monthly|May 6, 2006
Focus on hepatitis. Low rate of liver problems seen with LPV/rMichael Carter
IAPAC Monthly|January 20, 2007
Focus on hepatitis. HIV/HCV-coinfected may have worse survivalMichael Carter
IAPAC Monthly|April 2, 2004
HAART patients at greater risk of severe side effects than AIDSMichael Carter
IAPAC Monthly|April 27, 2004
IDV concentrations plummet with rifampicinMichael Carter
IAPAC Monthly|August 23, 2005
Sexual HCV transmission among HIV-negative gay menMichael Carter
Evidence-Based Nursing|May 9, 2002
The experiences of patients with rheumatoid arthritis admitted to hospital focused on 5 interrelated themesMichael Carter
IAPAC Monthly|April 2, 2004
French investigators warn of LPV/TDF/ddI interactionMichael Carter
Pageof 15

Showing results (11-20 of 145) with videos related to

Sort By:
Pageof 15
IAPAC Monthly|January 26, 2007
Focus on hepatitis. HCV protease inhibitor does well in early clinical trialMichael Carter
IAPAC Monthly|May 26, 2007
Frequent methamphetamine use, primary NNRTI resistanceMichael Carter
IAPAC Monthly|May 26, 2007
Focus on hepatitis. HIV/HCV coinfection and CVD riskMichael Carter
IAPAC Monthly|May 6, 2006
Focus on hepatitis. Low rate of liver problems seen with LPV/rMichael Carter
IAPAC Monthly|January 20, 2007
Focus on hepatitis. HIV/HCV-coinfected may have worse survivalMichael Carter
IAPAC Monthly|April 2, 2004
HAART patients at greater risk of severe side effects than AIDSMichael Carter
IAPAC Monthly|April 27, 2004
IDV concentrations plummet with rifampicinMichael Carter
IAPAC Monthly|August 23, 2005
Sexual HCV transmission among HIV-negative gay menMichael Carter
Evidence-Based Nursing|May 9, 2002
The experiences of patients with rheumatoid arthritis admitted to hospital focused on 5 interrelated themesMichael Carter
IAPAC Monthly|April 2, 2004
French investigators warn of LPV/TDF/ddI interactionMichael Carter
Pageof 15